Blood Cancer Resources
The Lymphoma Coalition
Lymphoma Research Foundation (LRF) Focus on Hodgkin Lymphoma (an LRF website) Cutaneous Lymphoma Foundation T-Cell Leukemia Lymphoma Foundation Focus on Anaplastic Large Cell Lymphoma (an LRF website) The Leukemia and Lymphoma Society
Information for patients
We are moving from promise to practice in the clinic.View our clinical trials
September is National
Blood Cancer Awareness Month
We're supporting Blood Cancer Awareness Month by providing these lymphoma resource links and a downloadable blood cancer awareness ribbon. Show your support and be a part of Blood Cancer Awareness Month.
Download the Blood Cancer Awareness Ribbon
Download the red blood cancer awareness ribbon and use it in your email signature, on your Facebook page, Twitter or other social media account to show your support during September.
Light The Night WalksLight The Night Walk® is a fundraising campaign of The Leukemia & Lymphoma Society. Light The Night Walk funds research to find cures and ensure access to treatments for all blood cancer patients. Coming together for a common goal, friends, families and co-workers form fundraising walk teams. Culminating in inspirational and memorable evening walks every fall, participants in nearly 200 communities across North America join together carrying illuminated lanterns to take steps to end cancer.
At Seattle Genetics, we're excited to show our passion for helping patients by forming teams at Light The Night Walks across the U.S. Will you join us?
Find a Light The Night Walk near you Make a donation to Team Seattle Genetics
Light it Red for LymphomaThroughout the month of September, buildings and iconic landmarks around the world Light it Red for Lymphoma to not only raise awareness of the disease, but to help provide hope to all those touched by lymphoma. Use #LightItRed in your social media posts showing your visit to a Light It Red site. Find a list of Light it Red for Lymphoma sites Learn how you can Light it Red
World Lymphoma Awareness Day - September 15On September 15, the global lymphoma community stands together to raise awareness of lymphomas, to tell the world that lymphoma is a cancer that can’t be ignored. Learn more
Educational ConferencesThe Lymphoma Research Foundation is committed to providing members of the lymphoma community with accurate, up-to-date information about the diagnosis and treatment of the disease with in-person educational conferences all around the U.S. The North American Educational Forum takes place in Chicago October 28-30.
Find details and register for a workshop now
About half of the blood cancers that occur are lymphomas, or cancers of the lymphatic system.
Hodgkin lymphoma is one of two major categories of lymphoma. It is distinguished from other types of lymphoma by the presence of one characteristic type of cell, known as the Reed-Sternberg cell. A defining attribute of the Reed-Sternberg cell is its expression of the CD30 antigen. The American Cancer Society estimates that more than 8,500 people will be diagnosed with Hodgkin lymphoma in the United States during 2016.
Non-Hodgkin lymphoma is the second major category of lymphoma and represents a diverse group of cancers that develop in the lymphatic system and are characterized by uncontrolled growth and accumulation of abnormal lymphocytes. Lymphocytes are a type of white blood cell that are responsible for defending the body against infection. Diffuse large B-cell lymphoma (DLBCL) is the most common form of NHL, accounting for up to 30 percent of newly diagnosed cases in the United States. According to the American Cancer Society, more than 72,500 people are expected to be diagnosed with non-Hodgkin lymphoma in the United States during 2016.
Leukemia is a type of cancer that affects the blood and bone marrow, the spongy center of bones where blood cells are formed. The disease develops when blood cells produced in the bone marrow grow out of control. The four most common types of leukemia are acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL).
Acute myeloid leukemia is a type of bone marrow cancer. The American Cancer Society estimates that nearly 20,000 cases of AML will be diagnosed in the United States during 2016, and more than 10,000 people will die from the disease.
Acute lymphoblastic leukemia (also called acute lymphocytic leukemia) is a type of blood and bone marrow cancer. The American Cancer Society estimates that more than 6,500 new cases of ALL will be diagnosed in the United States during 2016, and more than 1,400 people will die from the disease.